Business / Finance

RSS

Toshiba, Unfors RaySafe partner to improve clinical staff safety during interventional procedures

To improve clinical staff safety during interventional procedures and help monitor radiation dose, Toshiba America Medical Systems, Inc. has partnered with Unfors RaySafe, Inc. to offer a new dose monitoring and management tool for Infinix-i cardiovascular X-ray systems. The Unfors RaySafe i2 displays real-time dose exposure information, helping to make exams safer for all clinical staff.

22 Jul 2013

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, today announced the release of new findings concerning the effect of Bacillus-derived Hyaluronic Acid (HA) on the drug release of tramadol hydrochloride. The new research is to be presented as a scientific poster at the 2013 Controlled Release Society (CRS) annual meeting, July 21-24, Hawaii, USA.

22 Jul 2013

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

An investigation undertaken by Novozymes Biopharma DK has shown that when the corticosteroid dexamethasone is formulated in a cross-linked Hyaluronic acid (HA) hydrogel, the drug’s in vitro release time increases from under 10 minutes to approximately 15 hours. In addition, the in vivo half-life of dexamethasone is shown to plateau with stable dexamethasone concentration up to four hours after injection.

22 Jul 2013

UnitedHealth reports profit up 7.4 percent

The nation's largest health care insurer says membership is growing and medical costs have been lower than expected.

20 Jul 2013

NorthStar Anesthesia announces new partnership with MetroWest Medical Center

NorthStar Anesthesia announced today a new partnership with facilities on both campuses of MetroWest Medical Center. Framingham Union Hospital in Framingham, Mass. and Leonard Morse Hospital in Natick, Mass. serve local communities west of Boston and are the newest healthcare facilities to implement the NorthStar model of anesthesia care.

20 Jul 2013

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

Whittier Independent Practice Association, of Newburyport, Massachusetts, announced that it has signed an agreement with Alere Accountable Care Solutions to build a community-wide health information exchange.

20 Jul 2013

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

HCA and IASIS Healthcare LLC today announced the signing of a definitive agreement for the sale of three Tampa Bay hospitals—Palms of Pasadena Hospital, Memorial Hospital of Tampa and Town & Country Hospital—by IASIS to HCA West Florida.

19 Jul 2013

NGM Biopharmaceuticals announces completion of $50 million Series C financing

NGM Biopharmaceuticals, Inc. announced today the successful completion of a $50 million Series C financing to support advancing its portfolio of potential therapeutics for the treatment of diabetes, obesity and other cardio-metabolic diseases.

19 Jul 2013

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.

19 Jul 2013

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

Ensemble Therapeutics announces initiation of drug discovery collaboration with Alexion subsidiary

Ensemble Therapeutics, a biotechnology company developing Ensemblins, a novel class of small molecule therapeutics with the potential to modulate targets typically addressed by biologics, today announced the initiation of a drug discovery collaboration with a subsidiary of Alexion Pharmaceuticals, Inc., the global biopharmaceutical company focused on developing and commercializing life-transforming therapies for patients with life-threatening, ultra-rare disorders.

18 Jul 2013

Audentes Therapeutics closes $30 million Series A financing

Audentes Therapeutics, Inc., a recently founded biotechnology company dedicated to the development of innovative treatments for rare muscle diseases, today announced the closing of a $30 million Series A financing.

18 Jul 2013

Danaher reports 4% increase in Q2 revenues

Danaher Corporation today announced results for the second quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise noted.

From Danaher 18 Jul 2013

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that it has completed the sale of its rights to royalties from commercialization of the drug candidate ibrutinib to Royalty Pharma, the industry leader in acquiring royalty interests in marketed and late stage biopharmaceutical products, for $485 million in cash.

From Quest Diagnostics 18 Jul 2013

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

AbGenomics International announced today that it has raised $9.6 million in current financing round.

18 Jul 2013

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced today that it has signed an exclusive license agreement with the University of Maryland, Baltimore for a novel drug delivery platform, Nano-Polymer-Drug Conjugate Systems.

17 Jul 2013

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

ComQi, the global multi-channel message management company, and Aceso, a healthcare management and communications solutions provider, announced their partnership in serving the healthcare sector with turn-key digital media solutions.

17 Jul 2013

Mindray acquires ZONARE Medical Systems

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today that it has completed the acquisition of ZONARE Medical Systems, Inc., an ultrasound technology leader in the high-end radiology segment pursuant to the terms of the previously announced definitive agreement entered into on June 12, 2013.

From Mindray 17 Jul 2013

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Spectrum Pharmaceuticals, Inc., a biotechnology company with fully-integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that, through a wholly-owned subsidiary, the company entered into an agreement to acquire Talon Therapeutics, Inc., a biopharmaceutical company based in South San Francisco, California, and expects to complete the acquisition within one day.

17 Jul 2013

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

Sequella, a clinical-stage pharmaceutical company commercializing novel antibiotics to treat life-threatening infectious diseases, today announced that it has licensed Pfizer Inc's exclusive worldwide rights to develop and commercialize sutezolid, a Phase 2 oxazolidinone antibiotic currently in development for the treatment of tuberculosis.

17 Jul 2013

Business / Finance

Toshiba, Unfors RaySafe partner to improve clinical staff safety during interventional procedures

Drug release of tramadol hydrochloride increases from 1.9 to 7.5 hours by adding Novozymes Biopharma’s Hyasis®

Bacillus-derived Hyaluronic acid from Novozymes Biopharma, Hyasis®, increases in vitro drug release time from under 10 minutes to approximately 15 hours

UnitedHealth reports profit up 7.4 percent

NorthStar Anesthesia announces new partnership with MetroWest Medical Center

Whittier IPA signs agreement with Alere Accountable Care Solutions to build community-wide HIE

HCA signs definitive agreement to acquire three Tampa Bay hospitals from IASIS

NGM Biopharmaceuticals announces completion of $50 million Series C financing

Bausch + Lomb obtains option to license MIM-D3 for treatment of dry eye syndrome

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Ensemble Therapeutics announces initiation of drug discovery collaboration with Alexion subsidiary

Audentes Therapeutics closes $30 million Series A financing

Danaher reports 4% increase in Q2 revenues

Quest Diagnostics completes sale of ibrutinib commercialization rights to Royalty Pharma

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

ComQi, Aceso partner to serve healthcare sector with turn-key digital media solutions

Mindray acquires ZONARE Medical Systems

Spectrum Pharmaceuticals enters into agreement to acquire Talon Therapeutics

Sequella licenses Pfizer's exclusive worldwide rights to develop, commercialize sutezolid

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News